Teva-Valganciclovir

  • Generic name

    valganciclovir hydrochloride

  • Brand reference

    Valcyte®

  • Strength

    450 mg

  • DIN

    02413825

  • Therapeutic class

    Antiviral Agent

  • Therapeutic area

    Anti-Virals

  • Package size

    Bottle 60

  • Product code

    85764-0035

  • UPC

    068510177278

  • Generic name:

    valganciclovir hydrochloride

  • Brand reference:

    Valcyte®

  • Product code:

    85764-0035

  • Strength

    450 mg

  • DIN

    02413825

  • UPC:

    068510177278

  • Therapeutic class

    Antiviral Agent

  • Therapeutic area:

    Anti-Virals

  • Package size:

    Bottle 60

Composition

Active ingredient

valganciclovir hydrochloride


Non-medicinal ingredients

colloidal anhydrous silica, crospovidone, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, mannitol, microcrystalline cellulose, titanium dioxide and triacetin.

Product characteristics

  • Dosage form

    tablet

  • Shape

    -

  • Marking 1

    93

  • Marking 2

    5465

  • Colour

    pink

  • Secondary colour

    -

  • Scored

    -

  • Flavour

    -

  • Gluten

    currently not available

  • Latex

    not applicable

Disclaimers

All information about raw materials and/or allergen information for Teva Canada’s products is obtained from our suppliers and/or third-party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third-party affiliates and/or change in suppliers of the active and inactive ingredients that may occur over time, and all information provided herein is based on our last records on file.

Our manufacturing sites are not certified gluten-free. Raw materials and finished products are not tested for the presence of gluten. Therefore, the presence of trace amounts of gluten in the raw materials and in the finished products cannot be excluded.

"Latex" refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging, or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process; however, this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and/or packaging facilities may be wearing latex gloves.

Product monograph/consumer information leaflet


View monograph

Notice

We are modifying our product names to align with our corporate name change. Accordingly, please expect product monographs to contain the “Novo-”, “ratio-”, “ACT”, "CO" prefix or the new “Teva” prefix. These prefixes may be used interchangeably on the website.

Should you have any questions about our product names or our corporate name change, please do not hesitate to contact us. Our Customer Care department can be reached at 1-800-268-4127 regarding your inquiry.